196 related articles for article (PubMed ID: 32336187)
1. A de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia.
De Mingo Alemany MC; Mifsud Grau L; Moreno Macián F; Ferrer Lorente B; León Cariñena S
Channels (Austin); 2020 Dec; 14(1):175-180. PubMed ID: 32336187
[TBL] [Abstract][Full Text] [Related]
2. A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia.
Flanagan SE; Vairo F; Johnson MB; Caswell R; Laver TW; Lango Allen H; Hussain K; Ellard S
Pediatr Diabetes; 2017 Jun; 18(4):320-323. PubMed ID: 28318089
[TBL] [Abstract][Full Text] [Related]
3. [The third case report a patient with primary aldosteronism, seizures, and neurologic abnormalities (PASNA) syndrome de novo variant mutations in the CACNA1D gene].
Semenova NA; Ryzhkova OR; Strokova TV; Taran NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(12):49-52. PubMed ID: 30698561
[TBL] [Abstract][Full Text] [Related]
4. New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy.
Pinggera A; Mackenroth L; Rump A; Schallner J; Beleggia F; Wollnik B; Striessnig J
Hum Mol Genet; 2017 Aug; 26(15):2923-2932. PubMed ID: 28472301
[TBL] [Abstract][Full Text] [Related]
5. Biophysical classification of a
Hofer NT; Tuluc P; Ortner NJ; Nikonishyna YV; Fernándes-Quintero ML; Liedl KR; Flucher BE; Cox H; Striessnig J
Mol Autism; 2020; 11(1):4. PubMed ID: 31921405
[TBL] [Abstract][Full Text] [Related]
6. CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels.
Pinggera A; Lieb A; Benedetti B; Lampert M; Monteleone S; Liedl KR; Tuluc P; Striessnig J
Biol Psychiatry; 2015 May; 77(9):816-22. PubMed ID: 25620733
[TBL] [Abstract][Full Text] [Related]
7. CACNA1D-Related Channelopathies: From Hypertension to Autism.
Ortner NJ
Handb Exp Pharmacol; 2023; 279():183-225. PubMed ID: 36592224
[TBL] [Abstract][Full Text] [Related]
8. De novo CACNA1D Ca
Ortner NJ; Kaserer T; Copeland JN; Striessnig J
Pflugers Arch; 2020 Jul; 472(7):755-773. PubMed ID: 32583268
[TBL] [Abstract][Full Text] [Related]
9. Ca
Pinggera A; Striessnig J
J Physiol; 2016 Oct; 594(20):5839-5849. PubMed ID: 26842699
[TBL] [Abstract][Full Text] [Related]
10. Generation of the human induced pluripotent stem cell line (IBKMOLi002-A) from PBMCs of a patient carrying the heterozygous L271H mutation of the voltage-gated calcium channel subunit Ca
Tisch M; Carmen De Mingo Alemany M; Suarez-Cubero M; Fauth C; Defrancesco M; Zschocke J; Günther K; Edenhofer F
Stem Cell Res; 2022 May; 61():102784. PubMed ID: 35453044
[TBL] [Abstract][Full Text] [Related]
11. Gating defects of disease-causing de novo mutations in Ca
Pinggera A; Negro G; Tuluc P; Brown MJ; Lieb A; Striessnig J
Channels (Austin); 2018; 12(1):388-402. PubMed ID: 30465465
[TBL] [Abstract][Full Text] [Related]
12. Hyperinsulinemic Hypoglycemia Associated with a Ca
Kummer S; Rinné S; Seemann G; Bachmann N; Timothy K; Thornton PS; Pillekamp F; Mayatepek E; Bergmann C; Meissner T; Decher N
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897673
[TBL] [Abstract][Full Text] [Related]
13. Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene
Rinné S; Stallmeyer B; Pinggera A; Netter MF; Matschke LA; Dittmann S; Kirchhefer U; Neudorf U; Opp J; Striessnig J; Decher N; Schulze-Bahr E
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430690
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation associated with congenital hyperinsulinism.
Natarajan G; Aggarwal S; Merritt TA
Am J Perinatol; 2007 Aug; 24(7):401-4. PubMed ID: 17597441
[TBL] [Abstract][Full Text] [Related]
16. Congenital Hyperinsulinemic Hypoglycemia and Hyperammonemia due to Pathogenic Variants in GLUD1.
Roy K; Satapathy AK; Houhton JAL; Flanagan SE; Radha V; Mohan V; Sharma R; Jain V
Indian J Pediatr; 2019 Nov; 86(11):1051-1053. PubMed ID: 31119523
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.
Kitamoto T; Suematsu S; Yamazaki Y; Nakamura Y; Sasano H; Matsuzawa Y; Saito J; Omura M; Nishikawa T
J Clin Endocrinol Metab; 2016 Feb; 101(2):494-503. PubMed ID: 26606680
[TBL] [Abstract][Full Text] [Related]
18. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
19. Novel genes in primary aldosteronism.
Fischer E; Beuschlein F
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
[TBL] [Abstract][Full Text] [Related]
20. Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion.
González-Barroso MM; Giurgea I; Bouillaud F; Anedda A; Bellanné-Chantelot C; Hubert L; de Keyzer Y; de Lonlay P; Ricquier D
PLoS One; 2008; 3(12):e3850. PubMed ID: 19065272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
